MLEC official logo MLEC
MLEC 1-star rating from Upturn Advisory
Moolec Science SA Ordinary Shares (MLEC) company logo

Moolec Science SA Ordinary Shares (MLEC)

Moolec Science SA Ordinary Shares (MLEC) 1-star rating from Upturn Advisory
$0.44
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/12/2025: MLEC (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

1 star rating from financial analysts

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $3

1 Year Target Price $3

Analysts Price Target For last 52 week
$3 Target price
52w Low $0.39
Current$0.44
52w High $10.47

Analysis of Past Performance

Type Stock
Historic Profit -27.53%
Avg. Invested days 23
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/12/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 4.74M USD
Price to earnings Ratio -
1Y Target Price 3
Price to earnings Ratio -
1Y Target Price 3
Volume (30-day avg) 1
Beta -0.32
52 Weeks Range 0.39 - 10.47
Updated Date 12/14/2025
52 Weeks Range 0.39 - 10.47
Updated Date 12/14/2025
Dividends yield (FY) -
Basic EPS (TTM) -2.1

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -21.69%
Return on Equity (TTM) -174.68%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 24900319
Price to Sales(TTM) 0.21
Enterprise Value 24900319
Price to Sales(TTM) 0.21
Enterprise Value to Revenue 3.18
Enterprise Value to EBITDA -1.01
Shares Outstanding 10891761
Shares Floating 897815
Shares Outstanding 10891761
Shares Floating 897815
Percent Insiders 28.8
Percent Institutions 0.65

About Moolec Science SA Ordinary Shares

Exchange NASDAQ
Headquaters -
IPO Launch date 2023-01-03
CEO -
Sector Healthcare
Industry Biotechnology
Full time employees -
Full time employees -

Moolec Science SA, a science-based ingredient company, engages in developing ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology in Cayman Islands and internationally. It produces animal proteins in plants to heal the meat production system. The company is based in Grand Cayman, Cayman Islands.